Principles and challenges in access to experimental medicines
JAMA
.
2015 May 26;313(20):2023-4.
doi: 10.1001/jama.2015.4135.
Authors
Michael Rosenblatt
1
,
Bruce Kuhlik
1
Affiliation
1
Merck and Company, Kenilworth, New Jersey.
PMID:
25906392
DOI:
10.1001/jama.2015.4135
No abstract available
MeSH terms
Adult
Child
Clinical Trials as Topic*
Communication
Compassionate Use Trials*
Drug Industry
Drugs, Investigational*
Government Regulation
Health Services Accessibility
Humans
United States
Substances
Drugs, Investigational